Brian Park, PharmD

Drug Information Specialist https://www.clinicaladvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Infectious Diseases Information Center

Moderna’s COVID-19 Vaccine Gets Fast Track Designation

Brian Park, PharmD

May 14, 2020

The FDA has granted Fast Track designation to the vaccine candidate, mRNA-1273 (Moderna), against the novel coronavirus (SARS-CoV-2).

Sleep Information Center

Daridorexant Improves Sleep, Daytime Performance in Insomnia Study

Brian Park, PharmD

May 6, 2020

Idorsia announced positive topline results from a phase 3 study of daridorexant, an investigational dual orexin receptor antagonist, for the treatment of insomnia.

Vaccine Information Center

FDA Approves Quadrivalent Meningococcal Vaccine MenQuadfi

Brian Park, PharmD

April 28, 2020

The FDA has approved MenQuadfiTM Meningococcal (Groups A, C, Y, W; Sanofi Pasteur) Conjugate Vaccine for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y in patients aged ≥2 years.

Neurology Information Center

FDA Clears Hand-Held Vagus Nerve Stimulator for Migraine Prevention

Brian Park, PharmD

April 24, 2020

The FDA has approved an expanded indication for the gammaCore device to include prevention of migraine.

Infectious Diseases Information Center

Investigational Triple Antibody Cocktail Under Review for Ebola Virus Infection

Brian Park, PharmD

April 20, 2020

The FDA has accepted for Priority Review the Biologics License Application (BLA) for REGN-EB3 for the treatment of Ebola virus infection.

Practice Management Information Center

DEA: 2020 Drugs of Abuse Resource Guide Now Available

Brian Park, PharmD

April 17, 2020

The guide includes information on a drug’s origin, common street names, how it is abused, what effect it has on the mind and body, what the overdose effects are, and what its legal status is in the US.

Infectious Diseases Information Center

FDA OKs Blood Purification System for COVID-19 Patients Admitted to ICU

Brian Park, PharmD

April 13, 2020

The Agency believes that the ability to manage the cytokine storm associated with COVID-19 may decrease patient morbidity.

Pediatrics Information Center

Doxycycline, Clindamycin, Caffeine Citrate Labeling Updated With Pediatric Recommendations

Brian Park, PharmD

April 10, 2020

Data that informed these label changes came from research funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Infectious Diseases Information Center

FDA Issues Emergency Use Authorization for Point-of-Care COVID-19 Tests

Brian Park, PharmD

March 25, 2020

The FDA has issued emergency use authorization for two point-of-care diagnostics for the qualitative detection of SARS-CoV-2, the virus causing coronavirus disease 2019 (COVID-19).

Neurology Information Center

FDA Approves Nurtec ODT for Acute Treatment of Migraine

Brian Park, PharmD

March 23, 2020

The Food and Drug Administration (FDA) has approved Nurtec™ ODT (rimegepant; Biohaven) for the acute treatment of migraine with or without aura in adults.

Next post in Neurology Information Center